Shares of Indoco Remedies may come under pressure following it receiving three critical and four major observations from the UK-MHRA for its Goa factory. The United Kingdom - Medicines and Healthcare Products Regulatory Agency had inspected Indoco’s Goa manufacturing unit between March 14 and 16. The company is fully committed to respond to UK-MHRA at the earliest within the stipulated time, Indoco said in a statement to the stock exchanges.